Al-Ali H - Search Results

1

Functional Drug Screening of Small Molecule Inhibitors of Epigenetic Modifiers in Refractory AML Patients.

Dennison JL, Al-Ali H, Volmar CH, Brothers S, Watts J, Wahlestedt C, Lohse I. Dennison JL, et al. Cancers (Basel). 2022 Aug 24;14(17):4094. doi: 10.3390/cancers14174094. Cancers (Basel). 2022. PMID: 36077629 Free PMC article.

2

Gain of function of ASXL1 truncating protein in the pathogenesis of myeloid malignancies.

Yang H, Kurtenbach S, Guo Y, Lohse I, Durante MA, Li J, Li Z, Al-Ali H, Li L, Chen Z, Field MG, Zhang P, Chen S, Yamamoto S, Li Z, Zhou Y, Nimer SD, Harbour JW, Wahlestedt C, Xu M, Yang FC. Yang H, et al. Blood. 2018 Jan 18;131(3):328-341. doi: 10.1182/blood-2017-06-789669. Epub 2017 Nov 7. Blood. 2018. PMID: 29113963 Free PMC article.

3

Ex-vivo sensitivity profiling to guide clinical decision making in acute myeloid leukemia: A pilot study.

Swords RT, Azzam D, Al-Ali H, Lohse I, Volmar CH, Watts JM, Perez A, Rodriguez A, Vargas F, Elias R, Vega F, Zelent A, Brothers SP, Abbasi T, Trent J, Rangwala S, Deutsch Y, Conneally E, Drusbosky L, Cogle CR, Wahlestedt C. Swords RT, et al. Leuk Res. 2018 Jan;64:34-41. doi: 10.1016/j.leukres.2017.11.008. Epub 2017 Nov 11. Leuk Res. 2018. PMID: 29175379 Free PMC article. Clinical Trial.

4

Ex vivo drug sensitivity testing as a means for drug repurposing in esophageal adenocarcinoma.

Lohse I, Al-Ali H, Volmar CH, D Alvarez Trotta A, Brothers SP, Capobianco AJ, Wahlestedt C. Lohse I, et al. PLoS One. 2018 Sep 13;13(9):e0203173. doi: 10.1371/journal.pone.0203173. eCollection 2018. PLoS One. 2018. PMID: 30212533 Free PMC article.

5

Enhancement of BDNF Expression and Memory by HDAC Inhibition Requires BET Bromodomain Reader Proteins.

Sartor GC, Malvezzi AM, Kumar A, Andrade NS, Wiedner HJ, Vilca SJ, Janczura KJ, Bagheri A, Al-Ali H, Powell SK, Brown PT, Volmar CH, Foster TC, Zeier Z, Wahlestedt C. Sartor GC, et al. J Neurosci. 2019 Jan 23;39(4):612-626. doi: 10.1523/JNEUROSCI.1604-18.2018. Epub 2018 Nov 30. J Neurosci. 2019. PMID: 30504275 Free PMC article.

6

Ovarian Cancer Treatment Stratification Using Ex Vivo Drug Sensitivity Testing.

Lohse I, Azzam DJ, Al-Ali H, Volmar CH, Brothers SP, Ince TA, Wahlestedt C. Lohse I, et al. Anticancer Res. 2019 Aug;39(8):4023-4030. doi: 10.21873/anticanres.13558. Anticancer Res. 2019. PMID: 31366484 Free PMC article.

7

A novel strategy for combination of clofarabine and pictilisib is synergistic in gastric cancer.

Khalafi S, Zhu S, Khurana R, Lohse I, Giordano S, Corso S, Al-Ali H, Brothers SP, Wahlestedt C, Schürer S, El-Rifai W. Khalafi S, et al. Transl Oncol. 2022 Jan;15(1):101260. doi: 10.1016/j.tranon.2021.101260. Epub 2021 Nov 1. Transl Oncol. 2022. PMID: 34735897 Free PMC article.

8

Phenotypic Screening of Small-Molecule Inhibitors: Implications for Therapeutic Discovery and Drug Target Development in Traumatic Brain Injury.

Al-Ali H, Lemmon VP, Bixby JL. Al-Ali H, et al. Methods Mol Biol. 2016;1462:677-88. doi: 10.1007/978-1-4939-3816-2_37. Methods Mol Biol. 2016. PMID: 27604745

9

Identification of lead anti-human cytomegalovirus compounds targeting MAP4K4 via machine learning analysis of kinase inhibitor screening data.

Strang BL, Asquith CRM, Moshrif HF, Ho CM, Zuercher WJ, Al-Ali H. Strang BL, et al. PLoS One. 2018 Jul 26;13(7):e0201321. doi: 10.1371/journal.pone.0201321. eCollection 2018. PLoS One. 2018. PMID: 30048526 Free PMC article.

10

A Robust Phenotypic Screening Assay Utilizing Human Podocytes to Identify Agents that Modulate Lipid Droplets.

Gurumani M, Mallela SK, Varona J, Merscher S, Fornoni A, Al-Ali H. Gurumani M, et al. Methods Mol Biol. 2023;2625:163-174. doi: 10.1007/978-1-0716-2966-6_15. Methods Mol Biol. 2023. PMID: 36653642

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

200 results

Search Page